ESR1 and breast cancer: We further identified ER as a key transcriptional regulator of SEMA3C expression in ER+ breast cancer cells, establishing SEMA3C as a tumor vulnerability in ER+ breast cancer and providing a mechanistic link between the SEMA3C-ER pathway and growth signaling in ER+ breast cancer.